公開日期 | 題名 | 作者 | 關聯 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2021 | Ruxolitinib Combined with Gemcitabine against Cholangiocarcinoma Growth via the JAK2/STAT1/3/ALDH1A3 Pathway | Chung, SY; Hung, YP; Pan, YR; Chang, YC; Wu, CE; Hsu, DS; Chang, PM; Lu, ML; Huang, CY; Su, Y; Hsiao, M ; Yeh, CN; Chen, MH | BIOMEDICINES 9(8), 885 |